NCT01294410 Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT01293279 HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China Status COMPLETED Phase N/A
NCT01292655 Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT01290575 Multiple Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01285609 Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin Status COMPLETED Phase PHASE3
NCT01281228 The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes Status COMPLETED Phase NA
NCT01275794 Screening Epidemiological Program on Compensation Evaluation of Diabetes Mellitus Type 2 (DMT2) Patients on Oral Anti-diabetic (OAD) Monotherapy and Physicians Satisfaction of Their Usage Status COMPLETED Phase N/A
NCT01272856 Study on the Safety of Abatacept in Relapsing Polychondritis Status COMPLETED Phase PHASE1
NCT01267448 Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia Status COMPLETED Phase PHASE4
NCT01257412 Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone Status SUSPENDED Phase PHASE3
NCT01257204 Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection Status COMPLETED Phase PHASE2
NCT01254864 Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies Status COMPLETED Phase PHASE2
NCT01250366 Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects Status COMPLETED Phase PHASE1
NCT01245556 Safety and Efficacy Study of BMS-908662 in Combination With Ipilimumab in Subjects With Advanced Melanoma Status COMPLETED Phase PHASE1
NCT01244750 Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Status COMPLETED Phase N/A
NCT01241292 Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone Status COMPLETED Phase PHASE1
NCT01240980 Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B) Status COMPLETED Phase PHASE1